Mustang Bio Inc expected to post a loss of $1.81 a share - Earnings Preview

Mustang Bio

08/08/2023 03:08

* Mustang Bio Inc  MBIO.OQ   MBIO.O  is expected to show no
change
in quarterly revenue when it reports  results on August 9
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Mustang Bio Inc is
for a
loss of $1.81 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Mustang Bio
Inc
is $19​, above​ its last closing price of $4.65. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -2.98       -3.01      -2.06     Beat    31.6
 Dec. 31 2023  -2.70       -2.89      -2.70     Beat    6.5
 Sep. 30 2022  -2.98       -2.96      -2.70     Beat    8.9​
 Jun. 30 2022  -3.12       -3.12      -2.85     Beat    8.7
 ​​Mar.        -2.77       -2.76      -3.00     Missed  -8.7
 31 2022                                                
 Dec. 31 2021              -2.88      -3.30     Missed  -14.6​
 Sep. 30 2021  -2.65       -2.67      -2.85     Missed  -6.7
 Jun. 30 2021  -2.98       -2.96      -2.40     Beat    19
 This summary was machine generated August 8 at 02:07 GMT.  All
figures in US dollars  unless otherwise stated